{"groups":[{"description":"Adjuvant Chemotherapy:\n\nCapecitabine, 1500 mg/m\\^2/day, PO, Every 12 hrs on Days 1-14 of each cycle; Gemcitabine hydrochloride, 1000 mg/m\\^2, IV, Days 1 \\& 8 of each cycle.\n\nChemoradiotherapy:\n\nCapecitabine, 1330 mg/m\\^2/day, PO, Every 12 hrs, 7 days per week beginning the first day of RT and finishing the last day of RT; Radiation (RT): 3-dimensional conformal radiation therapy - 4,500 cGy over 5 weeks (5 days/week) in 180 cGy/fraction + 900 cGy during week 1 in 180 cGy fractions; intensity-modulated radiation therapy: 4,500 cGy over 5 weeks (5 days/week) in 180 cGy/fraction + 5,250 cGy in 210 cGy/fraction for a total of 25 fractions.","id":"FG000","title":"Adjuvant Chemotherapy + Chemoradiotherapy"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"3"}],"type":"Adverse Event"},{"reasons":[{"groupId":"FG000","numSubjects":"4"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"3"}],"type":"Progression"},{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"not protocol specified"},{"reasons":[{"groupId":"FG000","numSubjects":"26"}],"type":"Not eligible/not analyzable"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"105"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"79"}],"type":"Eligible and Analyzable"},{"achievements":[{"groupId":"FG000","numSubjects":"68"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"37"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}